Clinical feasibility of (neo)adjuvant taxane-based chemotherapy in older patients: analysis of >4,500 patients from four German randomized breast cancer trials

INTRODUCTION: Despite the fact that people older than 65 years of age have the highest incidence of developing breast cancer, these patients are excluded from clinical trials in most cases. Furthermore, most physicians tend towards therapy regimens without the use of dose-dense, highly active taxane...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Loibl, Sibylle, von Minckwitz, Gunter, Harbeck, Nadia, Janni, Wolfgang, Elling, Dirk, Kaufmann, Manfred, Eggemann, Holm, Nekljudova, Valentina, Sommer, Harald, Kiechle, Marion, Kümmel, Sherko
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2008
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2614510/
https://ncbi.nlm.nih.gov/pubmed/18796139
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr2144
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados